CAAS
RMD icon

Capital Asset Advisory Services’s ResMed RMD Stock Holding History

Capital Asset Advisory Services’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-159
Closed -$34K – 1324
2020
Q4 		$34K Buy
+159
New +$31.7K 0.01% 710

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Asset Advisory Services's RMD Position: Q1 2021 in Review

Capital Asset Advisory Services sold out of ResMed (RMD) in Q1 2021, closing a stake of 159 shares — an estimated $34K sold.

Capital Asset Advisory Services first reported a position in RMD in Q4 2020 and held it in 1 quarter. The position peaked at $34K in Q4 2020. 662 funds tracked by Wall St. Rank hold RMD as of Q1 2021.

  • Capital Asset Advisory Services reported no remaining ResMed position as of Q1 2021 after selling out during the quarter.
  • Capital Asset Advisory Services sold 159 ResMed shares in Q1 2021, an estimated $34K.
  • Capital Asset Advisory Services first reported a position in ResMed in Q4 2020 and held it in 1 quarter.
  • Capital Asset Advisory Services's ResMed position peaked at $34K in Q4 2020.
  • 662 funds tracked by Wall St. Rank held ResMed as of Q1 2021.

Based on Capital Asset Advisory Services's 13F filing for Q1 2021, filed 13 May 2021.